FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Mobikwik IPO and Sai Life Sciences IPO.
Mobikwik IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Sai Life Sciences IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Mobikwik IPO | Sai Life Sciences IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | SBI Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) |
Kotak Mahindra Capital Company Limited Iifl Securities Ltd Jefferies India Private Limited Morgan Stanley India Company Pvt Ltd |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL |
The total issue size of Mobikwik IPO is up to ₹572.00 Cr whereas the issue size of the Sai Life Sciences IPO is up to ₹3,042.62 Cr. The final issue price of Mobikwik IPO is ₹279.00 per share and of Sai Life Sciences IPO is .
Mobikwik IPO | Sai Life Sciences IPO | |
---|---|---|
Face Value | ₹2 per share | ₹1 per share |
Issue Price (Lower) | ₹265.00 per share | ₹522.00 per share |
Issue Price (Upper) | ₹279.00 per share | ₹549.00 per share |
Issue Price (Final) | ₹279.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 53 shares | 27 shares |
Fresh Issue Size | 2,05,01,792 shares | 1,73,04,189 shares |
Fresh Issue Size (Amount) | up to ₹572.00 Cr | up to ₹950.00 Cr |
OFS Issue Size | 3,81,16,934 shares | |
OFS Issue Size (Amount) | up to ₹2,092.62 Cr | |
Issue Size Total | 2,05,01,792 shares | 5,54,21,123 shares |
Issue Size Total (Amount) | up to ₹572.00 Cr | up to ₹3,042.62 Cr |
Mobikwik IPO opens on Dec 11, 2024, while Sai Life Sciences IPO opens on Dec 11, 2024. The closing date of Mobikwik IPO and Sai Life Sciences IPO is Dec 13, 2024, and Dec 13, 2024, respectively.
Mobikwik IPO | Sai Life Sciences IPO | |
---|---|---|
Anchor Bid Date | Dec 10, 2024 | Dec 10, 2024 |
Issue Open | Dec 11, 2024 | Dec 11, 2024 |
Issue Close | Dec 13, 2024 | Dec 13, 2024 |
Basis Of Allotment (Tentative) | Dec 16, 2024 | Dec 16, 2024 |
Initiation of Refunds (Tentative) | Dec 17, 2024 | Dec 17, 2024 |
Credit of Share (Tentative) | Dec 17, 2024 | Dec 17, 2024 |
Listing date (Tentative) | Dec 18, 2024 | Dec 18, 2024 |
Anchor Lockin End date 1 | Jan 15, 2025 | Jan 15, 2025 |
Anchor Lockin End date 2 | Mar 16, 2025 | Mar 16, 2025 |
Mobikwik IPO P/E ratio is 113.32, as compared to Sai Life Sciences IPO P/E ratio of 126.42.
Mobikwik IPO | Sai Life Sciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | One Mobikwik Systems Limited Financial Information (Restated Consolidated)One Mobikwik Systems Limited's revenue increased by 59% and profit after tax (PAT) rose by 117% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Sai Life Sciences Limited Financial Information (Restated Consolidated)Sai Life Sciences Limited's revenue increased by 20% and profit after tax (PAT) rose by 729% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 32.96% | 40.48% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 25.18% | 35.1% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 113.32 | 126.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹2295.45 Cr. | ₹11418.63 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 11.79%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 15.96%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.73 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹2.46 | ₹4.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 8.66%% | 8.13%% |
In the Mobikwik IPO retail investors (RII) are offered 20,50,179 shares while in Sai Life Sciences IPO retail investors are offered 20,50,179 shares. Qualified institutional buyers (QIB) are offered 61,50,538 shares in Mobikwik IPO and 1,10,84,225 shares in Sai Life Sciences IPO.
Mobikwik IPO | Sai Life Sciences IPO | |
---|---|---|
Anchor Investor Reserveration | 92,25,807 shares | 1,66,26,336 shares |
Market Maker Reserveration | ||
QIB | 61,50,538 shares | 1,10,84,225 shares |
NII | 30,75,269 shares | 83,13,168 shares |
RII | 20,50,179 shares | 1,93,97,392 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,12,75,986 shares | 3,87,94,785 shares |
Mobikwik IPO subscribed 21.61x in total, whereas Sai Life Sciences IPO subscribed 1.26x.
Mobikwik IPO | Sai Life Sciences IPO | |
---|---|---|
QIB (times) | 0.89x | 3.20x |
NII (times) | 31.72x | 0.60x |
Big NII (times) | 25.90x | 0.59x |
Small NII (times) | 43.36x | 0.63x |
RII (times) | 68.64x | 0.43x |
Employee (times) | ||
Other (times) | ||
Total (times) | 21.61x | 1.26x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|